Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy

ClinicalTrials.gov ID: NCT00261599

Public ClinicalTrials.gov record NCT00261599. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Dose-Controlled Study to Assess the Efficacy and Safety of AQUAVAN® (Fospropofol Disodium) Injection for Minimal to Moderate Sedation in Patients Undergoing Colonoscopy

Study identification

NCT ID
NCT00261599
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eisai Inc.
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

  • AQUAVAN® (fospropofol disodium) Injection Drug
  • Midazolam HCI Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2006
Primary completion
Not listed
Completion
Sep 30, 2006
Last update posted
Nov 6, 2008

2006

United States locations

U.S. sites
20
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
Clinical Research Associates Huntsville Alabama 35801
UCSF-Fresno/University Medical Center Fresno California 93702
Borland-Groover Clinic Jacksonville Florida 32256
Rockford Gastroenterology Associates Rockford Illinois 61107
Welborn Clinic Evansville Indiana 47713
Indiana University Medical Center/Clarian Health Partner Indianapolis Indiana 46202
Chevy Chase Clinical Research Chevy Chase Maryland 20815
Maryland Digestive Diseases Center Laurel Maryland 20707
Shah Associates Prince Frederick Maryland 20678
Oakland Colon & Rectal Associates Royal Oak Michigan 48067
Center for Digestive Health Troy Michigan 48098
Gastrointestinal Associates, PA Jackson Mississippi 39202
Research Associates of New York (New York Gastroenterology Associates) New York New York 10021
Asheville Gastroenterology Associates Asheville North Carolina 28801
WestHills Gastroenterology Associates Portland Oregon 97225
Memphis Gastroenterology Group, PC Germantown Tennessee 38138
Gastrointestinal Institute Nashville Tennessee 37203
Alamo Research Center San Antonio Texas 78215
Spokane Digestive Disease Center Spokane Washington 99204
Wisconsin Center for Advance Research Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00261599, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 6, 2008 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00261599 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →